The University of Chicago Header Logo

Connection

James Vardiman to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications James Vardiman has written about Clinical Trials, Phase II as Topic.
James Vardiman
Connection Strength
0.012
Clinical Trials, Phase II as Topic
  1. Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Cancer Res. 2001 Oct 01; 61(19):7233-9.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.